Cargando…

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

BACKGROUND: Acquired resistance to trastuzumab is a major clinical problem in the treatment of HER2-positive (HER2+) breast cancer patients. The selection of trastuzumab-resistant patients is a great challenge of precision oncology. The aim of this study was to identify novel epigenetic biomarkers a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palomeras, Sònia, Diaz-Lagares, Ángel, Viñas, Gemma, Setien, Fernando, Ferreira, Humberto J., Oliveras, Glòria, Crujeiras, Ana B., Hernández, Alejandro, Lum, David H., Welm, Alana L., Esteller, Manel, Puig, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612099/ https://www.ncbi.nlm.nih.gov/pubmed/31277676 http://dx.doi.org/10.1186/s13058-019-1160-x

Ejemplares similares

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
por: Pineda, Begoña, et al.
Publicado: (2019)

Circular RNA CpG island hypermethylation-associated silencing in human cancer
por: Ferreira, Humberto J., et al.
Publicado: (2018)

Epigenetic changes in cancer
por: Esteller, Manel
Publicado: (2011)

CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer
por: Ferreira, Humberto J., et al.
Publicado: (2012)

Impact of the Epigenetically Regulated Hoxa-5 Gene in Neural Differentiation from Human Adipose-Derived Stem Cells
por: Hernández, Rosa, et al.
Publicado: (2021)

PB1705: THE HISTONE MODIFIER SETD6 IS EPIGENETICALLY REGULATED IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND INTERFERES WITH PROLIFERATION AND GENE EXPRESSION
por: Veselinova, Yoana, et al.
Publicado: (2023)

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
por: Toll, Agustí, et al.
Publicado: (2016)

Epigenetic drugs: More than meets the eye
por: Esteller, Manel
Publicado: (2017)

Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing
por: Pontel, Lucas B., et al.
Publicado: (2022)

Hot topics in epigenetic mechanisms of aging: 2011
por: Berdasco, María, et al.
Publicado: (2012)

Breast Cancer Epigenetics: From DNA Methylation to microRNAs
por: Veeck, Jürgen, et al.
Publicado: (2010)

Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer
por: Nami, Babak, et al.
Publicado: (2021)

Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
por: Giró-Perafita, Ariadna, et al.
Publicado: (2017)

First Barcelona Conference on Epigenetics and Cancer
por: Palau, Anna, et al.
Publicado: (2014)

Epigenetic Disruption of the PIWI Pathway in Human Spermatogenic Disorders
por: Heyn, Holger, et al.
Publicado: (2012)

Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
por: Palomeras, Sònia, et al.
Publicado: (2018)

Molecular genetics of Chinese families with TGFBI corneal dystrophies
por: Zhang, Ting, et al.
Publicado: (2011)

Evaluation of TGFBI corneal dystrophy and molecular diagnostic testing
por: Chao-Shern, Connie, et al.
Publicado: (2019)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

Dynamic epigenetic age mosaicism in the human atherosclerotic artery
por: Zaina, Silvio, et al.
Publicado: (2022)

Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer
por: Rosselló-Tortella, Margalida, et al.
Publicado: (2020)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

Genotype-phenotype correlation of TGFBI corneal dystrophies in Polish patients
por: Nowińska, Anna K., et al.
Publicado: (2011)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

TGFBI gene mutations in a Korean population with corneal dystrophy
por: Cho, Kyong Jin, et al.
Publicado: (2012)

TGFBI expression is associated with a better response to chemotherapy in NSCLC
por: Irigoyen, Marta, et al.
Publicado: (2010)

The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression
por: Li, Bingyan, et al.
Publicado: (2012)

TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
por: Fico, Flavia, et al.
Publicado: (2020)

TGFBI is involved in the formation of polyploid cancer cells and the response to paclitaxel
por: Shang, Xiaobin, et al.
Publicado: (2021)

TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer
por: Lecker, Laura S.M., et al.
Publicado: (2021)

Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis
por: Ferreira, Humberto J, et al.
Publicado: (2014)

Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome
por: Simo-Riudalbas, L., et al.
Publicado: (2015)

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas
por: Martin-Castillo, Begoña, et al.
Publicado: (2015)

Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer?
por: Hanly, David J., et al.
Publicado: (2018)

Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
por: Ye, Xing-Ming, et al.
Publicado: (2014)

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
por: Blancafort, Adriana, et al.
Publicado: (2015)

Reduced penetrance in familial Avellino corneal dystrophy associated with TGFBI mutations
por: Cao, Wenping, et al.
Publicado: (2009)

Phenotype–genotype correlations in patients with TGFBI-linked corneal dystrophies in Taiwan
por: Hou, Yu-Chih, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c74ev2pvmvt8jrpldikfmvsak4